West Pharmaceutical Services Profit Margin 2010-2025 | WST

Current and historical gross margin, operating margin and net profit margin for West Pharmaceutical Services (WST) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. West Pharmaceutical Services net profit margin as of March 31, 2025 is 16.13%.
West Pharmaceutical Services Annual Profit Margins
West Pharmaceutical Services Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $16.250B $2.893B
West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical products in the Americas, Europe, the Middle East, Africa and the Asia Pacific. Its primary objective is to deliver quality products that cater to the exact product specifications and quality standards that customers expect and need. West Pharmaceutical operates through two segments: Proprietary Products and Contract-Manufactured Products.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $90.985B 21.97
Becton Dickinson (BDX) United States $50.300B 12.46
Cardinal Health (CAH) United States $39.205B 20.53
Straumann Holding AG (SAUHY) Switzerland $21.303B 0.00
Cooper (COO) United States $14.989B 19.32
Align Technology (ALGN) United States $14.532B 28.85
Henry Schein (HSIC) United States $9.027B 15.48
Merit Medical Systems (MMSI) United States $5.674B 27.43
DENTSPLY SIRONA (XRAY) United States $3.302B 9.86
CONMED (CNMD) United States $1.637B 12.25
STAAR Surgical (STAA) United States $0.849B 0.00
Lifevantage (LFVN) United States $0.164B 16.96
Pro-Dex (PDEX) United States $0.160B 17.50